Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by birch1on Jan 04, 2021 10:14pm

131 Views

Post# 32221418

Pfizer and Trillium Pharmaceutical

I'm in Trillium in a big way (TRIL). Pfizer bought in $25M at $13 per share and wouldn't be surprised to see something similar with vxl, but not at that sp. Something lower, but because of Goran's relationship and changing things with Covid, it wouldn't surprise me that they scoop up cheap shares to get in on this with the USAMI. Just a thought.

<< Previous

Bullboard Posts

Next >>

TELUS adds 347K customers in Q3